Liver resection for intrahepatic cholangiocarcinoma—single-center experience with 286 patients undergoing surgical exploration over a thirteen year period

Hauke Lang*, Janine Baumgart, Stefan Heinrich, Tobias Huber, Lisa Katharina Heuft, Rabea Margies, Jens Mittler, Felix Hahn, Tiemo S. Gerber, Friedrich Foerster, Arndt Weinmann, Jens U. Marquardt, Roman Kloeckner, Beate K. Straub, Fabian Bartsch

*Korrespondierende/r Autor/-in für diese Arbeit
1 Zitat (Scopus)


Background: Intrahepatic cholangiocarcinoma (iCCA) accounts for about 10% of primary liver cancer. Surgery is the only potentially curative treatment. We report on our current series of 229 consecutive hepatic resections for iCCA, which is one of the largest Western single-center series published so far. Methods: Between January 2008 to December 2020, a total of 286 patients underwent 307 surgical explorations for intended liver resection of iCCA at our department. Data were analyzed with regard to (1) preoperative treatment of tumor, (2) operative details, (3) perioperative morbidity and mortality, (4) histopathology, (5) outcome measured by tumor recurrence, treatment of recurrence and survival and (6) prognostic factors for overall and disease-free survival. Results: the resectability rate was 74.6% (229/307). In total, 202 primary liver resections, 21 repeated, 5 re-repeated, and 1 re-re-repeated liver resections were performed. In primary liver resections there were 77% (155/202) major hepatectomies. In 39/202 (20%) of patients additional hepatic wedge resections and in 87/202 (43%) patients additional 119 other surgical procedures were performed next to hepatectomy. Surgical radicality in first liver resections was 166 R0-, 33 R1-and 1 R2-resection. Following the first liver resection, the calculated 1-, 3-and 5-year-survival is 80%, 39%, and 22% with a median survival of 25.8 months. Until the completion of data acquisition, tumors recurred in 123/202 (60.9%) patients after a median of 7.5 months (range 1–87.2 months) after resection. A multivariate cox regression revealed tumor size (p < 0.001), T stage (p < 0.001) and N stage (p = 0.003) as independent predictors for overall survival. N stage (p = 0.040), preoperative therapy (p = 0.005), T stage (p = 0.004), tumor size (p = 0.002) and M stage (p = 0.001) were independent predictors for recurrence-free survival. Conclusions: For complete surgical removal, often extended liver resection in combination with complex vascular or biliary reconstruction is required. However, despite aggressive surgery, tumor recurrence is frequent and long-term oncological results are poor. This indicated that surgery alone is unlikely to make great strides in improving prognosis of patients with iCCA, instead clearly suggesting that liver resection should be incorporated in multimodal treatment concepts.

ZeitschriftJournal of Clinical Medicine
PublikationsstatusVeröffentlicht - 02.08.2021


Untersuchen Sie die Forschungsthemen von „Liver resection for intrahepatic cholangiocarcinoma—single-center experience with 286 patients undergoing surgical exploration over a thirteen year period“. Zusammen bilden sie einen einzigartigen Fingerprint.